Abstract
Long non-coding RNA LINC01106 is an lncRNA aberrantly expressed in gastric cancer (GC). However, the accurate function remains unclear. The objective of this investigation is to explore detailed regulatory mechanism of lncRNA LINC01106 in GC. The expression of lncRNA LINC01106, MYCN, and miR-34a-5p was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Cell viability was examined using MTT assay. Migratory and invasive abilities of GC cells were evaluated by transwell assay. The targeting relation among lncRNA LINC01106, MYCN, and miR-34a-5p was tested by dual-luciferase reporter (DLR) assay. Relative protein expression of MYCN was assessed via western blot. Besides, a xenograft mouse model was established to assess the role of LINC01106 in GC in vivo. LncRNA LINC01106 and MYCN expression were boosted and miR-34a-5p expression was reduced in GC cells and tissues compared to their controls. Functionally, decreased lncRNA LINC01106 or increased miR-34a-5p restrained GC cells in viability, invasion, and migration in vitro. LINC01106 down-regulation suppressed tumor growth of mice in vivo. In terms of mechanism, lncRNA LINC01106 directly targeted miR-34a-5p and was inversely correlated with miR-34a-5p. MYCN was targeted by miR-34a-5p and was inversely correlated with miR-34a-5p. There was a positive correlation between LINC01106 and MYCN. LINC01106 knockdown led to the suppression of cell invasion, migration, and viability, whereas these effects caused by LINC01106 knockdown were reversed by miR-34a-5p down-regulation or MYCN up-regulation in GC cells. Silencing of lncRNA LINC01106 attenuated cell viability, invasion, and migration by sponging miR-34a-5p to target MYCN in GC.
Similar content being viewed by others
References
Crew, K. D., & Neugut, A. I. (2006). Epidemiology of gastric cancer. World Journal of Gastroenterology, 12(3), 354–362. https://doi.org/10.3748/wjg.v12.i3.354
Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics. CA: A Cancer Journal for Clinicians, 69(1), 7–34. https://doi.org/10.3322/caac.21551
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
Sitarz, R., Skierucha, M., Mielko, J., Offerhaus, G. J. A., Maciejewski, R., & Polkowski, W. P. (2018). Gastric cancer: Epidemiology, prevention, classification, and treatment. Cancer Manag Res, 10, 239–248. https://doi.org/10.2147/CMAR.S149619
Cervantes, A., Roda, D., Tarazona, N., Rosello, S., & Perez-Fidalgo, J. A. (2013). Current questions for the treatment of advanced gastric cancer. Cancer Treatment Reviews, 39(1), 60–67. https://doi.org/10.1016/j.ctrv.2012.09.007
Wang, X., Arai, S., Song, X., Reichart, D., Du, K., Pascual, G., Tempst, P., Rosenfeld, M. G., Glass, C. K., & Kurokawa, R. (2008). Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature, 454(7200), 126–130. https://doi.org/10.1038/nature06992
Fatica, A., & Bozzoni, I. (2014). Long non-coding RNAs: New players in cell differentiation and development. Nature Reviews Genetics, 15(1), 7–21. https://doi.org/10.1038/nrg3606
Huang, Y., Zhang, J., Hou, L., Wang, G., Liu, H., Zhang, R., Chen, X., & Zhu, J. (2017). LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. Journal of Experimental & Clinical Cancer Research, 36(1), 194. https://doi.org/10.1186/s13046-017-0666-2
Luo, M., & Liang, C. (2020). LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p. Biological Research, 53(1), 14. https://doi.org/10.1186/s40659-020-00283-6
Pan, H., Ding, Y., Jiang, Y., Wang, X., Rao, J., Zhang, X., Yu, H., Hou, Q., & Li, T. (2021). LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p/COL1A2 axis. Cancer Cell International, 21(1), 7. https://doi.org/10.1186/s12935-020-01644-7
Han, W., Zhang, Z., He, B., Xu, Y., Zhang, J., & Cao, W. (2017). Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study. PLoS ONE, 12(8), e0183517. https://doi.org/10.1371/journal.pone.0183517
Mao, R., Wang, Z., Zhang, Y., Chen, Y., Liu, Q., Zhang, T., & Liu, Y. (2020). Development and validation of a novel prognostic signature in gastric adenocarcinoma. Aging (Albany, NY), 12(21), 22233–22252. https://doi.org/10.18632/aging.104161
Guo, L. L., Song, C. H., Wang, P., Dai, L. P., Zhang, J. Y., & Wang, K. J. (2015). Competing endogenous RNA networks and gastric cancer. World Journal of Gastroenterology, 21(41), 11680–11687. https://doi.org/10.3748/wjg.v21.i41.11680
Bhaskaran, M., & Mohan, M. (2014). MicroRNAs: History, biogenesis, and their evolving role in animal development and disease. Veterinary Pathology, 51(4), 759–774. https://doi.org/10.1177/0300985813502820
Meng, H., Li, Y. Y., Han, D., & Zhang, C. Y. (2019). MiRNA-93-5p promotes the biological progression of gastric cancer cells via Hippo signaling pathway. European Review for Medical and Pharmacological Sciences, 23(11), 4763–4769.
Wang, C., Huang, Y., Zhang, J., & Fang, Y. (2020). MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH1. Experimental and Molecular Pathology. https://doi.org/10.1016/j.yexmp.2020.104449
Hu, S., Zheng, Q., Wu, H., Wang, C., Liu, T., & Zhou, W. (2017). miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Life Sciences, 177, 15–19. https://doi.org/10.1016/j.lfs.2017.03.019
Hu, Y., Pu, Q., Cui, B., & Lin, J. (2015). MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2. International Journal of Clinical and Experimental Pathology, 8(8), 8921–8928.
Wei, B., Huang, Q. Y., Huang, S. R., Mai, W., & Zhong, X. G. (2015). MicroRNA34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET. Molecular Medicine Reports, 12(4), 5255–5261. https://doi.org/10.3892/mmr.2015.4110
Zheng, F., Li, J., Ma, C., Tang, X., Tang, Q., Wu, J., Chai, X., Xie, J., Yang, X. B., & Hann, S. S. (2020). Novel regulation of miR-34a-5p and HOTAIR by the combination of berberine and gefitinib leading to inhibition of EMT in human lung cancer. Journal of Cellular and Molecular Medicine, 24(10), 5578–5592. https://doi.org/10.1111/jcmm.15214
Ma, Y., Fan, B., Ren, Z., Liu, B., & Wang, Y. (2019). Long noncoding RNA DANCR contributes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p/JAG1 pathway. Oncotargets and Therapy, 12, 5485–5497. https://doi.org/10.2147/OTT.S197009
Sun, Z., Zhang, B., & Cui, T. (2018). Long non-coding RNA XIST exerts oncogenic functions in pancreatic cancer via miR-34a-5p. Oncology Reports, 39(4), 1591–1600. https://doi.org/10.3892/or.2018.6245
Bartel, D. P. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136(2), 215–233. https://doi.org/10.1016/j.cell.2009.01.002
Zuo, Y., Zheng, W., Liu, J., Tang, Q., Wang, S. S., & Yang, X. S. (2020). MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells. Neoplasma, 67(1), 93–101. https://doi.org/10.4149/neo_2019_190202N106
Xu, X. P., Peng, X. Q., Yin, X. M., Liu, Y., & Shi, Z. Y. (2020). miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation. Acta Histochemica, 122(6), 151576. https://doi.org/10.1016/j.acthis.2020.151576
He, J., Zhao, H., Liu, X., Wang, D., Wang, Y., Ai, Y., & Yang, J. (2020). Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosomemediated circHMGCS1 via the miR34a5p/SGPP1 axis. Oncology Reports, 44(6), 2429–2442. https://doi.org/10.3892/or.2020.7783
Meyer, N., & Penn, L. Z. (2008). Reflecting on 25 years with MYC. Nature Reviews Cancer, 8(12), 976–990. https://doi.org/10.1038/nrc2231
Liu, K., Wang, S., Liu, Y., Gu, J., Gu, S., Xu, Z., Zhang, R., Wang, Z., Ma, H., Chen, Y., & Ji, L. (2016). Overexpression of MYCN promotes proliferation of non-small cell lung cancer. Tumour Biology, 37(9), 12855–12866. https://doi.org/10.1007/s13277-016-5236-2
Yasukawa, K., Liew, L. C., Hagiwara, K., Hironaka-Mitsuhashi, A., Qin, X. Y., Furutani, Y., Tanaka, Y., Nakagama, H., Kojima, S., Kato, T., Ochiya, T., & Gailhouste, L. (2020). MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion. Cancer Science, 111(3), 869–880. https://doi.org/10.1111/cas.14292
Liu, T., Liu, Y., Wei, C., Yang, Z., Chang, W., & Zhang, X. (2020). LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/MYH9 axis. Biomedicine & Pharmacotherapy, 121, 109607. https://doi.org/10.1016/j.biopha.2019.109607
Wu, F., Gao, H., Liu, K., Gao, B., Ren, H., Li, Z., & Liu, F. (2019). The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1alpha axis. Oncotargets and Therapy, 12, 657–667. https://doi.org/10.2147/OTT.S175521
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020). Gastric cancer. Lancet, 396(10251), 635–648. https://doi.org/10.1016/S0140-6736(20)31288-5
Gu, Y., Huang, Y., Sun, Y., Liang, X., Kong, L., Liu, Z., & Wang, L. (2020). Long non-coding RNA LINC01106 regulates colorectal cancer cell proliferation and apoptosis through the STAT3 pathway. Nan Fang Yi Ke Da Xue Xue Bao, 40(9), 1259–1264. https://doi.org/10.12122/j.issn.1673-4254.2020.09.06
Gao, X., Yu, L., Zhang, J., & Xue, P. (2020). Silencing of long non-coding RNA LINC01106 suppresses the proliferation, migration and invasion of endometrial cancer cells through regulating the miR-449a/MET axis. Oncotargets and Therapy, 13, 9643–9655. https://doi.org/10.2147/OTT.S264642
Guo, K., Gong, W., Wang, Q., Gu, G., Zheng, T., Li, Y., Li, W., Fang, M., Xie, H., Yue, C., Yang, J., & Zhu, Z. (2020). LINC01106 drives colorectal cancer growth and stemness through a positive feedback loop to regulate the Gli family factors. Cell Death & Disease, 11(10), 869. https://doi.org/10.1038/s41419-020-03026-3
Meng, L., Xing, Z., Guo, Z., & Liu, Z. (2020). LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Cell Death & Disease, 11(12), 1063. https://doi.org/10.1038/s41419-020-03236-9
Paraskevopoulou, M. D., & Hatzigeorgiou, A. G. (2016). Analyzing MiRNA-LncRNA interactions. Methods in Molecular Biology, 1402, 271–286. https://doi.org/10.1007/978-1-4939-3378-5_21
Jiang, X., Guo, S., Zhang, Y., Zhao, Y., Li, X., Jia, Y., Xu, Y., & Ma, B. (2020). LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2019.109422
Li, S., Zhu, K., Liu, L., Gu, J., Niu, H., & Guo, J. (2020). lncARSR sponges miR-34a-5p to promote colorectal cancer invasion and metastasis via hexokinase-1-mediated glycolysis. Cancer Science, 111(10), 3938–3952. https://doi.org/10.1111/cas.14617
Ma, E., Wang, Q., Li, J., Zhang, X., Guo, Z., & Yang, X. (2020). LINC01006 facilitates cell proliferation, migration and invasion in prostate cancer through targeting miR-34a-5p to up-regulate DAAM1. Cancer Cell International, 20, 515. https://doi.org/10.1186/s12935-020-01577-1
Bracken, C. P., Scott, H. S., & Goodall, G. J. (2016). A network-biology perspective of microRNA function and dysfunction in cancer. Nature Reviews Genetics, 17(12), 719–732. https://doi.org/10.1038/nrg.2016.134
Song, C., Lu, P., Sun, G., Yang, L., & Wang, Z. (2017). miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis. Biochemical and Biophysical Research Communications, 482(1), 22–27. https://doi.org/10.1016/j.bbrc.2016.11.037
Muller, S., Raulefs, S., Bruns, P., Afonso-Grunz, F., Plotner, A., Thermann, R., Jager, C., Schlitter, A. M., Kong, B., Regel, I., Roth, W. K., Rotter, B., Hoffmeier, K., Kahl, G., Koch, I., Theis, F. J., Kleeff, J., Winter, P., & Michalski, C. W. (2015). Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Molecular Cancer, 14, 94. https://doi.org/10.1186/s12943-015-0358-5
Li, S., Chen, X., Liu, X., Yu, Y., Pan, H., Haak, R., Schmidt, J., Ziebolz, D., & Schmalz, G. (2017). Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. Oral Oncology, 73, 1–9. https://doi.org/10.1016/j.oraloncology.2017.07.026
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hong, S., Li, Q., Yang, Y. et al. Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of Gastric Cancer Cells by Targeting miR-34a-5p/MYCN Axis. Mol Biotechnol 64, 144–155 (2022). https://doi.org/10.1007/s12033-021-00402-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-021-00402-y